Affinity DataKd: 0.540nMAssay Description:Binding constant for PCTK1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 0.860nMAssay Description:Binding constant for PCTK2 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 0.940nMAssay Description:Binding constant for CDC2L5 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 0.950nMAssay Description:Binding constant for PCTK2 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 1.10nMAssay Description:Binding constant for PCTK1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 1.5nMAssay Description:Binding constant for CDK11 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 1.5nMpH: 7.4 T: 2°CAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 1.5nMAssay Description:Binding constant for CDK11 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 3.20nMAssay Description:Binding constant for CDC2L5 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 4.90nMAssay Description:Binding affinity to CDK13 (unknown origin) assessed as dissociation constantMore data for this Ligand-Target Pair
Affinity DataKd: 4.90nMAssay Description:Binding affinity to partial length human wild-type CDK13 expressed in mammalian expression system assessed as dissociation constant by DiscoverX KINO...More data for this Ligand-Target Pair
Affinity DataKd: 5.20nMAssay Description:Binding constant for CDC2L2 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 7.10nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 7.10nMAssay Description:Binding constant for PCTK1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 7.10nMAssay Description:Binding constant for PCTK1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 7.20nMAssay Description:Binding constant for PFTAIRE2 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 8.40nMAssay Description:Binding constant for CDC2L1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 8.60nMAssay Description:Binding affinity to human CDK13 (694 to 1039 residues)/CyclinK (1 to 267 residues) expressed in baculovirus infected in Sf9 cells by Biolayer interfe...More data for this Ligand-Target Pair
Affinity DataKd: 10nMAssay Description:Binding affinity to wild-type partial length human CDK11 (M1 to N360 residues) expressed in bacterial expression system by Kinomescan assayMore data for this Ligand-Target Pair
Affinity DataKd: 10nMAssay Description:Binding affinity to wild-type partial length human CDK11 (M1 to N360 residues) expressed in bacterial expression system by Kinomescan assayMore data for this Ligand-Target Pair
Affinity DataKd: 11nMAssay Description:Binding constant for PFTK1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 13nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 13nMAssay Description:Binding constant for PCTK2 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 13nMAssay Description:Binding constant for full-length PCTK2More data for this Ligand-Target Pair
Affinity DataKd: 14nMAssay Description:Binding constant for PCTK3 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 15nMAssay Description:Binding constant for PCTK2 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 15nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 15nMAssay Description:Binding constant for full-length PCTK2More data for this Ligand-Target Pair
Affinity DataKd: 16nMAssay Description:Binding constant for PFTK1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 16nMAssay Description:Binding affinity to human CDK12 (715 to 1052 residues)/CyclinK (1 to 267 residues) expressed in baculovirus infected in Sf9 cells by Biolayer interfe...More data for this Ligand-Target Pair
Affinity DataKd: 17nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 17nMAssay Description:Binding constant for PFTK1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 17nMAssay Description:Binding constant for full-length PFTK1More data for this Ligand-Target Pair
Affinity DataKd: 17nMAssay Description:Binding affinity to human CDK13 (694 to 1039 residues)/CyclinK (1 to 267 residues) expressed in baculovirus infected in Sf9 cells by Biolayer interfe...More data for this Ligand-Target Pair
Affinity DataKd: 20nMAssay Description:Binding constant for PCTK3 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 21nMAssay Description:Binding constant for PCTK1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 23nMAssay Description:Binding constant for CDC2L5 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 23nMAssay Description:Binding constant for PCTK1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 23nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 24nMAssay Description:Binding constant for PCTK1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 24nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 24nMAssay Description:Binding constant for PCTK1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 25nMAssay Description:Average Binding Constant for PCTK1; NA=Not Active at 10 uMMore data for this Ligand-Target Pair
Affinity DataKd: 25nMAssay Description:Binding affinity to partial length wild-type human CDK19 (M1 to N360 residues) expressed in bacterial expression system by KINOMEscan assayMore data for this Ligand-Target Pair
Affinity DataKd: <25nMAssay Description:Kinase-tagged T7 phage strains were grown in parallel in 24-well blocks in an E. coli host derived from the BL21 strain. E. coli were grown to log-ph...More data for this Ligand-Target Pair
Affinity DataKd: <25nMAssay Description:Kinase-tagged T7 phage strains were grown in parallel in 24-well blocks in an E. coli host derived from the BL21 strain. E. coli were grown to log-ph...More data for this Ligand-Target Pair
Affinity DataKd: <25nMAssay Description:Kinase-tagged T7 phage strains were grown in parallel in 24-well blocks in an E. coli host derived from the BL21 strain. E. coli were grown to log-ph...More data for this Ligand-Target Pair
Affinity DataKd: <25nMAssay Description:Kinase-tagged T7 phage strains were grown in parallel in 24-well blocks in an E. coli host derived from the BL21 strain. E. coli were grown to log-ph...More data for this Ligand-Target Pair
Affinity DataKd: <25nMAssay Description:Kinase-tagged T7 phage strains were grown in parallel in 24-well blocks in an E. coli host derived from the BL21 strain. E. coli were grown to log-ph...More data for this Ligand-Target Pair